1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis

Technology appraisal guidance [TA624] Published: 19 February 2020

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 141 KB 18 February 2020  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 240 KB 23 January 2020  
  • Committee papers PDF 7 MB 23 January 2020  
  • Public committee slides PDF 846 KB 23 January 2020  

Invitation to participate

  • Final scope PDF 197 KB 29 March 2019  
  • Final stakeholder list PDF 202 KB 03 April 2019